[go: up one dir, main page]

TN2009000199A1 - Heteromonocyclic compound and use thereof - Google Patents

Heteromonocyclic compound and use thereof

Info

Publication number
TN2009000199A1
TN2009000199A1 TNP2009000199A TN2009000199A TN2009000199A1 TN 2009000199 A1 TN2009000199 A1 TN 2009000199A1 TN P2009000199 A TNP2009000199 A TN P2009000199A TN 2009000199 A TN2009000199 A TN 2009000199A TN 2009000199 A1 TN2009000199 A1 TN 2009000199A1
Authority
TN
Tunisia
Prior art keywords
formula
compound
group represented
diseases
heteromonocyclic compound
Prior art date
Application number
TNP2009000199A
Other languages
English (en)
Inventor
Takanobu Kuroita
Hiroki Sakamoto
Hideyuki Igawa
Minoru Sasaki
Kouhei Asano
Tsuyoshi Maekawa
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of TN2009000199A1 publication Critical patent/TN2009000199A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TNP2009000199A 2006-11-24 2009-05-20 Heteromonocyclic compound and use thereof TN2009000199A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2006317839 2006-11-24
JP2007232106 2007-09-06
PCT/JP2007/073004 WO2008062905A2 (fr) 2006-11-24 2007-11-21 Composé hétéromonocyclique et ses utilisations

Publications (1)

Publication Number Publication Date
TN2009000199A1 true TN2009000199A1 (en) 2010-10-18

Family

ID=39205144

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2009000199A TN2009000199A1 (en) 2006-11-24 2009-05-20 Heteromonocyclic compound and use thereof

Country Status (21)

Country Link
US (2) US20080207654A1 (fr)
EP (2) EP2256115A1 (fr)
JP (1) JP2010510962A (fr)
KR (1) KR20090085117A (fr)
AR (1) AR063912A1 (fr)
AU (1) AU2007322608A1 (fr)
BR (1) BRPI0719060A2 (fr)
CA (1) CA2670404A1 (fr)
CL (1) CL2007003352A1 (fr)
CO (1) CO6231035A2 (fr)
CR (1) CR10847A (fr)
EA (1) EA200970510A1 (fr)
EC (1) ECSP099461A (fr)
IL (1) IL198819A0 (fr)
MA (1) MA30985B1 (fr)
MX (1) MX2009005449A (fr)
NO (1) NO20092415L (fr)
PE (1) PE20081228A1 (fr)
TN (1) TN2009000199A1 (fr)
TW (1) TW200829581A (fr)
WO (1) WO2008062905A2 (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7103906B1 (en) 2000-09-29 2006-09-05 International Business Machines Corporation User controlled multi-device media-on-demand system
WO2002031701A2 (fr) 2000-10-11 2002-04-18 United Video Properties, Inc. Systemes et procedes de stockage de donnees sur les serveurs d'un systeme de transmission de media sur demande
US8086575B2 (en) 2004-09-23 2011-12-27 Rovi Solutions Corporation Methods and apparatus for integrating disparate media formats in a networked media system
US9681105B2 (en) 2005-12-29 2017-06-13 Rovi Guides, Inc. Interactive media guidance system having multiple devices
US8607287B2 (en) 2005-12-29 2013-12-10 United Video Properties, Inc. Interactive media guidance system having multiple devices
JP2010510962A (ja) * 2006-11-24 2010-04-08 武田薬品工業株式会社 複素単環化合物およびその用途
US7803940B2 (en) * 2006-11-24 2010-09-28 Takeda Pharmaceutical Company Limited Heteromonocyclic compound or a salt thereof having strong antihypertensive action, insulin sensitizing activity and the like production thereof and use thereof for prophylaxis or treatment of cardiovascular diseases, metabolic diseases and/or central nervous system diseases
US20090019492A1 (en) 2007-07-11 2009-01-15 United Video Properties, Inc. Systems and methods for mirroring and transcoding media content
JP4892649B1 (ja) * 2009-01-30 2012-03-07 武田薬品工業株式会社 縮合環化合物及びその用途
EP2399917A1 (fr) 2009-02-23 2011-12-28 Kowa Company, Ltd. Nouveaux composés comprenant une structure de 3-(5-alcoxypyrimidin-2-yl) pyrimidin-4(3h)-one et médicaments les comprenant
EP2420501A4 (fr) * 2009-04-17 2012-08-29 Kowa Co Nouveau composé ayant une structure 3-hétéroarylpyrimidin-4-(3h)-one et préparation pharmaceutique contenant celui-ci
US20120046308A1 (en) 2009-05-29 2012-02-23 Kowa Company, Ltd. Novel alpha-phenoxybenzeneacetic acid derivative and pharmaceutical preparation comprising same
US20120122906A1 (en) 2009-08-27 2012-05-17 Kowa Company, Ltd. Novel sulfonamide derivative and pharmaceutical product containing same
US9014546B2 (en) 2009-09-23 2015-04-21 Rovi Guides, Inc. Systems and methods for automatically detecting users within detection regions of media devices
DK2484675T3 (en) * 2009-09-29 2015-01-12 Kowa Co Novel phenylpyridinderivat and pharmaceutical comprehensive this
WO2011077711A1 (fr) * 2009-12-22 2011-06-30 興和株式会社 Nouveau dérivé de 2-pyridone et produit pharmaceutique le contenant
JPWO2011105099A1 (ja) * 2010-02-25 2013-06-20 興和株式会社 新規な４−アルコキシピリミジン構造を有する化合物及びこれを含有する医薬
US20130165446A1 (en) * 2010-05-11 2013-06-27 Takashi Fujita Benzo-or pyrido-imidazole derivative
WO2012011592A1 (fr) * 2010-07-23 2012-01-26 武田薬品工業株式会社 Composé hétérocyclique et application de celui-ci
PH12013500657A1 (en) 2010-10-07 2013-05-06 Takeda Pharmaceuticals Co 1,4-oxazepane derivatives
HUE040101T2 (hu) 2010-12-06 2019-02-28 Aclaris Therapeutics Inc Szubsztituált piridinon-piridinil-származékok
US9359300B2 (en) 2010-12-06 2016-06-07 Confluence Life Sciences, Inc. Methyl/difluorophenyl-methoxy substituted pyridinone-pyridinyl compounds, methyl-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds, and methyl-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds
WO2012078673A1 (fr) 2010-12-06 2012-06-14 Confluence Life Sciences, Inc. Composés urée-pyridine substitués
US8507499B2 (en) 2010-12-06 2013-08-13 Confluence Life Sciences, Inc. Substituted indole/indazole-pyrimidinyl compounds
HUE028252T2 (en) * 2011-03-14 2016-12-28 Kowa Co New phenylpyridine derivative and drug containing it
EP2567959B1 (fr) 2011-09-12 2014-04-16 Sanofi Dérivés d'amide d'acide 6-(4-hydroxy-phényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase
US9056110B2 (en) 2011-12-06 2015-06-16 Confluence Life Sciences, Inc. Substituted pyrimidinone-phenyl-pyrimidinyl compounds
PT2794597T (pt) * 2011-12-21 2018-01-16 Ono Pharmaceutical Co Derivados de piridinona e pirimidinona como inibidores do fator xia
JO3470B1 (ar) 2012-10-08 2020-07-05 Merck Sharp & Dohme مشتقات 5- فينوكسي-3h-بيريميدين-4-أون واستخدامها كمثبطات ناسخ عكسي ل hiv
DK3003039T3 (da) 2013-06-07 2021-05-25 Aclaris Therapeutics Inc Methyl/fluor-pyridinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser og fluor-pyrimidinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser
ES2761571T3 (es) 2013-06-20 2020-05-20 Bayer Cropscience Ag Derivados de arilsulfuro y arilsulfóxido como acaricidas e insecticidas
BR112015031155A2 (pt) 2013-06-20 2017-07-25 Bayer Cropscience Ag derivados de sulfureto de arila e derivados de aril sulfóxido como acaricidas e inseticidas
US9674563B2 (en) 2013-11-04 2017-06-06 Rovi Guides, Inc. Systems and methods for recommending content
JP6454348B2 (ja) 2013-12-19 2019-01-16 サンシャイン・レイク・ファーマ・カンパニー・リミテッドＳｕｎｓｈｉｎｅ Ｌａｋｅ Ｐｈａｒｍａ Ｃｏ．，Ｌｔｄ． 窒素複素環誘導体およびその医薬品への応用
US10004740B2 (en) 2014-04-01 2018-06-26 Merck Sharp & Dohme Corp. Prodrugs of HIV reverse transcriptase inhibitors
HUE051080T2 (hu) 2014-12-10 2021-03-01 Ono Pharmaceutical Co Dihidroindolizinon származék
MX2019000512A (es) 2016-07-12 2019-05-02 Bayer Cropscience Ag Compuestos biciclicos como plaguicidas.
KR101984121B1 (ko) * 2017-08-21 2019-05-30 보령제약 주식회사 피리미디논 유도체 화합물 및 이의 용도
CN115484952B (zh) 2020-03-27 2024-10-18 阿克拉瑞斯治疗股份有限公司 被取代的吡啶酮-吡啶基化合物的方法、组合物和结晶形式
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411980A (en) * 1989-07-28 1995-05-02 Merck & Co., Inc. Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists
ATE113281T1 (de) * 1989-08-02 1994-11-15 Takeda Chemical Industries Ltd Pyrazol-derivate, verfahren zu deren herstellung und anwendung.
JPH03218371A (ja) 1989-08-02 1991-09-25 Takeda Chem Ind Ltd ピラゾール誘導体
CA2036304C (fr) * 1990-02-15 2001-04-17 Takehiko Naka Derives de la pyrimidinedione; preparation et utilisation
JP3032844B2 (ja) 1990-02-15 2000-04-17 武田薬品工業株式会社 ピリミジンジオン誘導体
JP3114073B2 (ja) 1990-03-07 2000-12-04 武田薬品工業株式会社 アンジオテンシンｉｉ拮抗薬−含窒素異項環化合物
CA2037630C (fr) * 1990-03-07 2001-07-03 Akira Morimoto Composes heterocycliques renfermant de l'azote, methode de production et applications correspondantes
US5166206A (en) * 1990-03-30 1992-11-24 Merck & Co., Inc. Substituted pyrimidines, pyrimidinones and pyridopyrimidines
US5472967A (en) * 1991-02-20 1995-12-05 Synthelabo 4-pyrimidinone derivatives their preparation and their application in therapy
IL102183A (en) * 1991-06-27 1999-11-30 Takeda Chemical Industries Ltd Biphenyl substituted heterocyclic compounds their production and pharmaceutical compositions comprising them
IT1250749B (it) * 1991-08-02 1995-04-21 Luso Farmaco Inst Composti eterociclici ad attivita' a ii antagonista
DE69319391T2 (de) 1992-09-14 1998-10-29 Takeda Chemical Industries Ltd 1,2,4-Oxadiazolyl oder 1,2,4-Thiadiazolyl-Derivate als Angiotensin II Antagonisten
JPH06239859A (ja) 1992-09-14 1994-08-30 Takeda Chem Ind Ltd アンギオテンシンｉｉ拮抗作用を有する環状化合物およびその用途
DE69330593T2 (de) * 1992-12-22 2002-06-27 Takeda Chemical Industries, Ltd. Heterocyclische Verbindungen mit Angiotensin-II-antagonistischer Wirkung und ihre Anwendung
JP3412887B2 (ja) 1992-12-22 2003-06-03 武田薬品工業株式会社 アンギオテンシンｉｉ拮抗作用を有する複素環化合物およびその用途
US20010020100A1 (en) * 1994-06-14 2001-09-06 G.D. Searle & Co. N-substituted-1, 2, 4-triazolone compounds for treatment of cardiovascular disorders
US6025372A (en) 1997-04-04 2000-02-15 Merck & Co., Inc. Somatostatin agonists
US6057338A (en) 1997-04-04 2000-05-02 Merck & Co., Inc. Somatostatin agonists
WO1999022735A1 (fr) 1997-10-30 1999-05-14 Merck & Co., Inc. Agonistes de la somatostatine
AR035016A1 (es) 1999-08-25 2004-04-14 Takeda Chemical Industries Ltd Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
AU7556800A (en) 1999-10-07 2001-05-10 Tadeka Chemical Industries, Ltd. Amine derivatives
HK1045991B (en) 1999-11-10 2004-12-10 Takeda Pharmaceutical Company Limited 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
WO2001082925A1 (fr) 2000-04-28 2001-11-08 Takeda Chemical Industries, Ltd. Antagonistes de l'hormone concentrant la melanine
CA2408913A1 (fr) 2000-05-16 2001-11-22 Takeda Chemical Industries, Ltd. Antagoniste de l'hormone de concentration de la melanine
AU6951601A (en) 2000-07-13 2002-01-30 Takeda Chemical Industries Ltd Lipid-rich plaque inhibitors
EP1437351A4 (fr) 2001-10-19 2005-06-01 Takeda Pharmaceutical Derive d'amine
KR20040081123A (ko) 2002-01-11 2004-09-20 다케다 야쿠힌 고교 가부시키가이샤 쿠마린 유도체, 이의 제조 방법 및 용도
EP1564213A4 (fr) 2002-11-22 2009-05-27 Takeda Pharmaceutical Derives d'imidazole, leur procede de production et d'utilisation
US7803940B2 (en) * 2006-11-24 2010-09-28 Takeda Pharmaceutical Company Limited Heteromonocyclic compound or a salt thereof having strong antihypertensive action, insulin sensitizing activity and the like production thereof and use thereof for prophylaxis or treatment of cardiovascular diseases, metabolic diseases and/or central nervous system diseases
JP2010510962A (ja) * 2006-11-24 2010-04-08 武田薬品工業株式会社 複素単環化合物およびその用途

Also Published As

Publication number Publication date
IL198819A0 (en) 2010-02-17
US20080207654A1 (en) 2008-08-28
CO6231035A2 (es) 2010-12-20
EP2256115A1 (fr) 2010-12-01
AU2007322608A1 (en) 2008-05-29
MX2009005449A (es) 2009-06-02
CL2007003352A1 (es) 2008-07-04
KR20090085117A (ko) 2009-08-06
BRPI0719060A2 (pt) 2014-02-04
JP2010510962A (ja) 2010-04-08
EA200970510A1 (ru) 2009-12-30
ECSP099461A (es) 2009-11-30
AR063912A1 (es) 2009-02-25
EP2074117A2 (fr) 2009-07-01
US20100056526A1 (en) 2010-03-04
NO20092415L (no) 2009-08-17
TW200829581A (en) 2008-07-16
CR10847A (es) 2009-07-13
AU2007322608A2 (en) 2009-07-16
CA2670404A1 (fr) 2008-05-29
MA30985B1 (fr) 2009-12-01
WO2008062905A2 (fr) 2008-05-29
PE20081228A1 (es) 2008-10-29
WO2008062905A3 (fr) 2008-12-04

Similar Documents

Publication Publication Date Title
TN2009000199A1 (en) Heteromonocyclic compound and use thereof
TN2012000152A1 (en) Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes
UY31803A (es) Compuesto cristalino
CO6382126A2 (es) Compuestos heteroaromaticos fusionados y espirociclicos para el tratamiento de infecciones bacterianas
UA102251C2 (ru) Производные аминодигидротиазина как ингибиторы васе для лечения болезни альцгеймера
MY168201A (en) Agricultural And Horticultural Fungicidal Composition
MY148429A (en) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
PH12012500903A1 (en) N1 - pyrazolospiroketone acetyl-coa carboxylase inhibitors
TN2012000248A1 (en) Novel spiropiperidine compounds
PH12013500880A1 (en) Pyrazole aminopyrimidine derivatives as lrrk2 modulators
MX358682B (es) Derivados de pirazolo [1,5a]pirimidina y de tieno[3,2b] pirimidina como moduladores de la cinasa asociada al receptor de la interleucina 4 (irak4).
MX2014006026A (es) Derivados de aminopirimidina como moduladores de proteina cinasa 2 rica en unidades repetitivas de leucina (lrrk2).
JO2741B1 (en) Spiro-cyclic nitroblast as protease inhibitors
NO20091858L (no) Hydrobenzamid derivater som inhibitorer av HSP90
GEP20166481B (en) (crystalline forms of hydrochloride salt of (4a-r, 9a-s)-1-(1h-benzoimidazole-5-carbonyl)-2, 3, 4, 4a, 9, 9a-hexa- hydro-1h-indeno [2, 1-b] pyridine-6-carbonitrile and their use as hsd 1 inhibitors
GEP20166483B (en) Phenyl-3-aza-bicyclo[3.1.0] hex-3-yl-methanones and the use thereof as medicament
WO2007108936A3 (fr) Azacyclylamines avec substitution n en tant qu'antagonistes de l'histamine-3
NO20082096L (no) Azaindol-2-karboksamidderivativer
UA109290C2 (uk) Спільні кристали і солі інгібіторів ccr3
MX2010002899A (es) Derivados de azaciclilisoquinolinona e isoindolinona como antagonistas de la histamina-3.
GEP20135806B (en) Lactams as beta secretase inhibitors
WO2007136668A3 (fr) N-benzoyle et n-benzylpyrrolidin-3-ylamines comme antagonistes de l'histamine-3
EA200700909A1 (ru) Азаиндолкарбоксамиды
JO2999B1 (ar) مركب ثلاثي حلقي و استخدامه الدوائي
MX2008011576A (es) Compuestos de imidazo[2,1-b]tiazol sustituidos y su uso para la produccion de farmacos.